Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 10:54 PM ET

Pharmaceuticals

Company Overview of Glaxosmithkline Biologicals S.A.

Company Overview

Glaxosmithkline Biologicals S.A. researches, develops, manufactures, and supplies vaccines. Its vaccination products are used to tackle various diseases, such as rabies, diphtheria, tetanus, and yellow fever, as well as polio, measles, mumps, and rubella and hepatitis B. Glaxosmithkline Biologicals S.A. was formerly known as SmithKline Beecham Biologicals S.A. and changed its name to GlaxoSmithKline Biologicals S.A. in 2000. The company was founded in 1945 and is based in Rixensart, Belgium. Glaxosmithkline Biologicals S.A. operates as a subsidiary of GlaxoSmithKline plc.

Rue de l'institut 89

Rixensart,  1330

Belgium

Founded in 1945

Phone:

32 2 656 81 11

Fax:

32 2 656 80 00

Key Executives for Glaxosmithkline Biologicals S.A.

Chief Executive of GlaxoSmithKline PLC
Age: 49
Compensation as of Fiscal Year 2014.

Glaxosmithkline Biologicals S.A. Key Developments

GSK Vaccines Presents at BIO-Europe Spring 2015, Mar-09-2015

GSK Vaccines Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Arabio Signs Agreement with GSK for Local Production of Vaccines

GSK Vaccines and Glaxo Saudi Arabia Limited (GSAL) have signed an agreement with ARABIO under which a number of vaccines will be manufactured in Saudi Arabia. The vaccines to be manufactured locally include Infanrix hexa - used in the prevention of Diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b (Hib) - and Rotarix - used in the prevention of symptoms caused by rotavirus infection. Under the agreement, GSK Vaccines will transfer knowledge related to the vaccines to GSAL and ARABIO.

Similar Private Companies By Industry

Company Name Region
Omega Pharma NV Europe
Bio-Fyt Pharma NV Europe
THT s.a Europe
Janssen Pharmaceutica NV Europe
Dafra Pharma International Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Glaxosmithkline Biologicals S.A., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.